BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 27390862)

  • 21. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.
    Phi JH; Wang KC; Park SH; Kim IH; Kim IO; Park KD; Ahn HS; Lee JY; Son YJ; Kim SK
    J Neurooncol; 2012 Feb; 106(3):619-26. PubMed ID: 21863401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in intracranial ependymomas in children.
    Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
    J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas.
    Koos B; Bender S; Witt H; Mertsch S; Felsberg J; Beschorner R; Korshunov A; Riesmeier B; Pfister S; Paulus W; Hasselblatt M
    Clin Cancer Res; 2011 Jun; 17(11):3631-7. PubMed ID: 21493867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of MicroRNAs with the Clinicopathologic Characteristics of Ependymoma.
    Ahram M; Amarin JZ; Suradi HH; Abdelhamid SS; Makhamreh MM; Bawadi RM; Al-Hussaini M
    J Mol Neurosci; 2018 Nov; 66(3):307-313. PubMed ID: 30255441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.
    Montgomery EY; Thirunavu V; Pagadala M; Shlobin NA; Plant-Fox AS; Lam S; DeCuypere M
    J Neurosurg Pediatr; 2023 Feb; 31(2):132-142. PubMed ID: 36433871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
    Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
    Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ependymoma.
    Reni M; Gatta G; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2007 Jul; 63(1):81-9. PubMed ID: 17482475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relevance of localization and grading in intracranial ependymomas of childhood.
    Ernestus RI; Schröder R; Stützer H; Klug N
    Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA and miRNA Expression Analyses of the
    Gruszka R; Zakrzewski K; Liberski PP; Zakrzewska M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both location and age predict survival in ependymoma: a SEER study.
    McGuire CS; Sainani KL; Fisher PG
    Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
    Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
    J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment results in patients with intracranial ependymomas.
    Boström A; Boström J; Hartmann W; Pietsch T; Feuss M; von Lehe M; Simon M
    Cent Eur Neurosurg; 2011 Aug; 72(3):127-32. PubMed ID: 21630189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
    Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.
    Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R
    Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
    Ramaswamy V; Hielscher T; Mack SC; Lassaletta A; Lin T; Pajtler KW; Jones DT; Luu B; Cavalli FM; Aldape K; Remke M; Mynarek M; Rutkowski S; Gururangan S; McLendon RE; Lipp ES; Dunham C; Hukin J; Eisenstat DD; Fulton D; van Landeghem FK; Santi M; van Veelen ML; Van Meir EG; Osuka S; Fan X; Muraszko KM; Tirapelli DP; Oba-Shinjo SM; Marie SK; Carlotti CG; Lee JY; Rao AA; Giannini C; Faria CC; Nunes S; Mora J; Hamilton RL; Hauser P; Jabado N; Petrecca K; Jung S; Massimi L; Zollo M; Cinalli G; Bognár L; Klekner A; Hortobágyi T; Leary S; Ermoian RP; Olson JM; Leonard JR; Gardner C; Grajkowska WA; Chambless LB; Cain J; Eberhart CG; Ahsan S; Massimino M; Giangaspero F; Buttarelli FR; Packer RJ; Emery L; Yong WH; Soto H; Liau LM; Everson R; Grossbach A; Shalaby T; Grotzer M; Karajannis MA; Zagzag D; Wheeler H; von Hoff K; Alonso MM; Tuñon T; Schüller U; Zitterbart K; Sterba J; Chan JA; Guzman M; Elbabaa SK; Colman H; Dhall G; Fisher PG; Fouladi M; Gajjar A; Goldman S; Hwang E; Kool M; Ladha H; Vera-Bolanos E; Wani K; Lieberman F; Mikkelsen T; Omuro AM; Pollack IF; Prados M; Robins HI; Soffietti R; Wu J; Metellus P; Tabori U; Bartels U; Bouffet E; Hawkins CE; Rutka JT; Dirks P; Pfister SM; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Ellison DW; Taylor MD
    J Clin Oncol; 2016 Jul; 34(21):2468-77. PubMed ID: 27269943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Management of Pediatric Ependymomas.
    Lin FY; Chintagumpala M
    Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.